^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             37    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991002    
                           13991004 13991007 13991009    
                           13991010 16591001 16591003    
                           16591006 17601002 17601003    
                           17601005 17601007 17601012    
                           17601014 17601025 17661002    
                           17661004 17661006 19691001    
                           19731001 19731004 19731006    
                           19831001 19831005 19831008    
                           19901003                      
      AVISITN         4    1 4 8 12                      
      trtn            3    1 2 3                         
      SSNRISN         2    1 2                           
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      AGEGR1N         1    1                             
      wk12            2    0 1                           


                          Dimensions

              Covariance Parameters            10
              Columns in X                     28
              Columns in Z                      0
              Subjects                         37
              Max Obs per Subject               4


 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read             121
          Number of Observations Used             121
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       357.18273431                
          1              2       324.92665264      0.01598088
          2              1       323.80867915      0.00189127
          3              1       323.68701981      0.00004787
          4              1       323.68414186      0.00000005
          5              1       323.68413899      0.00000000
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.9034
                UN(2,1)     id           0.2153
                UN(2,2)     id           0.9527
                UN(3,1)     id           0.1951
                UN(3,2)     id           0.5515
                UN(3,3)     id           1.2437
                UN(4,1)     id           0.4237
                UN(4,2)     id           0.7030
                UN(4,3)     id           1.0170
                UN(4,4)     id           1.6649
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                        Fit Statistics

             -2 Res Log Likelihood           323.7
             AIC (Smaller is Better)         343.7
             AICC (Smaller is Better)        345.9
             BIC (Smaller is Better)         359.8


                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         33.50          0.0001


 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                           Num     Den
     Effect                 DF      DF    F Value    Pr > F

     BASE                    1    35.1       8.13    0.0073
     trtn                    2    32.2       0.09    0.9104
     wk12                    1    19.8       0.69    0.4159
     SSNRISN                 1    31.7       0.01    0.9379
     BASE*wk12               1    19.8       1.42    0.2469
     trtn*AGEGR1N            0                             
     trtn*wk12               2    19.6       0.43    0.6545
     AGEGR1N*wk12            0                             
     trtn*AGEGR1N*wk12       0                             


 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                     Pooled
                     Age
                     Group             Standard
 Effect        trtn  1 (N)   Estimate     Error    DF  t Value

 trtn*AGEGR1N  1     1        -1.2246    0.3553  32.3    -3.45
 trtn*AGEGR1N  2     1        -1.2019    0.3085  35.1    -3.90
 trtn*AGEGR1N  3     1        -1.0462    0.3503  39.6    -2.99

                      Least Squares Means
 
                    Pooled
                    Age
                    Group
Effect        trtn  1 (N)   Pr > |t|   Alpha     Lower     Upper

trtn*AGEGR1N  1     1         0.0016    0.05   -1.9481   -0.5011
trtn*AGEGR1N  2     1         0.0004    0.05   -1.8282   -0.5757
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                    Pooled
                    Age
                    Group
Effect        trtn  1 (N)   Pr > |t|   Alpha     Lower     Upper

trtn*AGEGR1N  3     1         0.0048    0.05   -1.7544   -0.3380
 
 
 
 
 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class       Levels    Values

      id              22    10631001 10631002 10631003    
                            11601002 11601006 11601007    
                            13031001 13581001 13581010    
                            13581014 13991002 13991004    
                            13991007 13991009 16591001    
                            17601005 17601007 17601014    
                            17661004 19731006 19831001    
                            19901003                      
      AVISITN          4    1 4 8 12                      
      SSNRISN1         2    0 1                           


                          Dimensions

              Covariance Parameters            10
              Columns in X                     12
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Columns in Z                      0
              Subjects                         22
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read              72
          Number of Observations Used              72
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       216.01204637                
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          1              2       192.72641018      0.00537721
          2              1       192.50575319      0.00025302
          3              1       192.49616806      0.00000095
          4              1       192.49613315      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           1.2622
                UN(2,1)     id           0.3142
                UN(2,2)     id           0.8956
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(3,1)     id           0.2683
                UN(3,2)     id           0.7164
                UN(3,3)     id           1.5361
                UN(4,1)     id           0.4503
                UN(4,2)     id           0.7969
                UN(4,3)     id           1.0446
                UN(4,4)     id           1.4680


                        Fit Statistics

             -2 Res Log Likelihood           192.5
             AIC (Smaller is Better)         212.5
             AICC (Smaller is Better)        216.6
             BIC (Smaller is Better)         223.4
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         23.52          0.0051


                 Type 3 Tests of Fixed Effects
 
                            Num     Den
    Effect                   DF      DF    F Value    Pr > F

    BASE                      1    19.7       6.20    0.0219
    trtn1                     0                             
    wk12                      0                             
    SSNRISN1                  1    17.1       0.26    0.6161
    AGEGR1N1                  0                             
    BASE*wk12                 1      12       1.75    0.2109
    trtn1*AGEGR1N1            0                             
    trtn1*wk12                0                             
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                            Num     Den
    Effect                   DF      DF    F Value    Pr > F

    wk12*AGEGR1N1             0                             
    trtn1*wk12*AGEGR1N1       0                             


                           Estimates
 
                              Standard
Label               Estimate     Error    DF  t Value  Pr > |t|

1 ACT-PBO  Week 4    -0.1997    0.4471  19.4    -0.45    0.6601
2 ACT-PBO  Week 4    Non-est                                   
1 ACT-PBO  Week 12   -0.3915    0.6865    17    -0.57    0.5760
2 ACT-PBO  Week 12   Non-est                                   

 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Estimates
 
       Label                Alpha       Lower       Upper

       1 ACT-PBO  Week 4     0.05     -1.1342      0.7348
       2 ACT-PBO  Week 4                                 
       1 ACT-PBO  Week 12    0.05     -1.8397      1.0568
       2 ACT-PBO  Week 12                                


                           Contrasts
 
                                           Num    Den
 Label                                      DF     DF   F Value

 Treatment*Week 4*Subgroup Interaction                         
 Treatment*Week 12*Subgroup Interaction                        

 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Contrasts
 
        Label                                    Pr > F

        Treatment*Week 4*Subgroup Interaction          
        Treatment*Week 12*Subgroup Interaction         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class       Levels    Values

      id              28    10631001 10631003 11601002    
                            11601006 13031001 13031004    
                            13581001 13581010 13581014    
                            13991010 16591003 16591006    
                            17601002 17601003 17601007    
                            17601012 17601025 17661002    
                            17661004 17661006 19691001    
                            19731001 19731004 19731006    
                            19831001 19831005 19831008    
                            19901003                      
      AVISITN          4    1 4 8 12                      
      SSNRISN1         2    0 1                           
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Covariance Parameters            10
              Columns in X                     12
              Columns in Z                      0
              Subjects                         28
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read              88
          Number of Observations Used              88
          Number of Observations Not Used           0


 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       264.63732462                
          1              4       238.36480971      0.03974299
          2              1       236.20994252      0.01020719
          3              1       235.68208271      0.00135084
          4              1       235.61791600      0.00003487
          5              1       235.61637549      0.00000003
          6              1       235.61637427      0.00000000


                   Convergence criteria met.                    


 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5763
                UN(2,1)     id           0.2544
                UN(2,2)     id           1.3700
                UN(3,1)     id           0.2414
                UN(3,2)     id           0.9580
                UN(3,3)     id           1.7531
                UN(4,1)     id           0.2258
                UN(4,2)     id           1.0967
                UN(4,3)     id           1.4684
                UN(4,4)     id           2.1445


                        Fit Statistics

             -2 Res Log Likelihood           235.6
             AIC (Smaller is Better)         255.6
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                        Fit Statistics

             AICC (Smaller is Better)        258.8
             BIC (Smaller is Better)         268.9


                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         29.02          0.0006


                 Type 3 Tests of Fixed Effects
 
                            Num     Den
    Effect                   DF      DF    F Value    Pr > F

    BASE                      1    24.9       3.90    0.0593
    trtn2                     0                             
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                            Num     Den
    Effect                   DF      DF    F Value    Pr > F

    wk12                      0                             
    SSNRISN1                  1    23.9       0.07    0.7925
    AGEGR1N1                  0                             
    BASE*wk12                 1    13.6       0.23    0.6397
    trtn2*AGEGR1N1            0                             
    trtn2*wk12                0                             
    wk12*AGEGR1N1             0                             
    trtn2*wk12*AGEGR1N1       0                             


 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Estimates
 
                               Standard
Label                Estimate     Error    DF  t Value  Pr > |t|

1 ACT-PBO    Week 4  -0.05212    0.3011  24.9    -0.17    0.8640
2 ACT-PBO  Week 4     Non-est                                   
1 ACT-PBO  Week 12    -0.3786    0.5992  18.1    -0.63    0.5354
2 ACT-PBO  Week 12    Non-est                                   

                           Estimates
 
      Label                 Alpha       Lower       Upper

      1 ACT-PBO    Week 4    0.05     -0.6723      0.5681
      2 ACT-PBO  Week 4                                  
      1 ACT-PBO  Week 12     0.05     -1.6367      0.8796
      2 ACT-PBO  Week 12                                 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Contrasts
 
                                           Num    Den
 Label                                      DF     DF   F Value

 Treatment*Week 4*Subgroup Interaction                         
 Treatment*Week 12*Subgroup Interaction                        

                           Contrasts
 
        Label                                    Pr > F

        Treatment*Week 4*Subgroup Interaction          
        Treatment*Week 12*Subgroup Interaction         
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
